Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spruce Biosciences (SPRB) Retained Earnings (2022 - 2025)

Spruce Biosciences (SPRB) has disclosed Retained Earnings for 4 consecutive years, with -$289.2 million as the latest value for Q4 2025.

  • Quarterly Retained Earnings fell 15.57% to -$289.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$289.2 million through Dec 2025, down 15.57% year-over-year, with the annual reading at -$289.2 million for FY2025, 15.57% down from the prior year.
  • Retained Earnings for Q4 2025 was -$289.2 million at Spruce Biosciences, down from -$274.6 million in the prior quarter.
  • The five-year high for Retained Earnings was -$3000.0 in Q3 2023, with the low at -$289.2 million in Q4 2025.
  • Average Retained Earnings over 4 years is -$173.3 million, with a median of -$203.0 million recorded in 2023.
  • The sharpest move saw Retained Earnings surged 100.0% in 2023, then crashed 7556866.67% in 2024.
  • Over 4 years, Retained Earnings stood at -$149.3 million in 2022, then crashed by 32.09% to -$197.2 million in 2023, then decreased by 26.89% to -$250.3 million in 2024, then fell by 15.57% to -$289.2 million in 2025.
  • According to Business Quant data, Retained Earnings over the past three periods came in at -$289.2 million, -$274.6 million, and -$266.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.